Protective Effects of Sodium-Glucose Transporter 2 Inhibitors on Atrial Fibrillation and Atrial Flutter: A Systematic Review and Meta- Analysis of Randomized Placebo-Controlled Trials

BACKGROUND: Hyperglycemia is associated with an increased risk of developing atrial fibrillation (AF) and atrial flutter (AFL). Sodium-glucose transporter 2 inhibitors (SGLT2i) have been reported to prevent AF/AFL in some studies, but not others. Therefore, a meta-analysis was performed to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Daobo, Liu, Yingying, Hidru, Tesfaldet Habtemariam, Yang, Xiaolei, Wang, Yunsong, Chen, Cheng, Li, Ka Hou Christien, Tang, Yuqi, Wei, Yushan, Tse, Gary, Xia, Yunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018283/
https://www.ncbi.nlm.nih.gov/pubmed/33815278
http://dx.doi.org/10.3389/fendo.2021.619586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018283/
https://www.ncbi.nlm.nih.gov/pubmed/33815278
http://dx.doi.org/10.3389/fendo.2021.619586

Ejemplares similares